Report Detail

Request for Sample of this report

Medical Devices & Consumables Global Rapamycin Coated Stent Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

  • RnM4661445
    • |
  • 31 December, 2025
    • |
  • Global
    • |
  • 130 Pages
    • |
  • GIR
    • |
  • Medical Devices & Consumables

According to our (Global Info Research) latest study, the global Rapamycin Coated Stent market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
Rapamycin drug coated stent is a medical device used for coronary intervention treatment. The drug coating of the stent contains rapamycin (also known as sirolimus), which is a drug that inhibits vascular restenosis. The drug will be released onto the vascular wall around the stent, thereby reducing the risk of vascular restenosis. Rapamycin coated stents are mainly used for interventional treatment of coronary artery diseases, such as coronary artery stenosis or occlusion. It can help restore blood flow and reduce myocardial ischemia.
This report is a detailed and comprehensive analysis for global Rapamycin Coated Stent market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Rapamycin Coated Stent market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Rapamycin Coated Stent market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Rapamycin Coated Stent market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Rapamycin Coated Stent market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Rapamycin Coated Stent
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Rapamycin Coated Stent market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include QualiMe, Cardionovum, MicroPort, B. Braun, P+F Products + Features GmbH, Terumo, Biotronik, USM Healthcare, Concept Medical Inc, MicroPort Scientific Corporation, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Rapamycin Coated Stent market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Cobalt Chromium Alloy Material
Stainless Steel Material
Others
Market segment by Application
Hospital
Clinic
Others
Major players covered
QualiMe
Cardionovum
MicroPort
B. Braun
P+F Products + Features GmbH
Terumo
Biotronik
USM Healthcare
Concept Medical Inc
MicroPort Scientific Corporation
Lepu Medical Technology
JW Medical Systems
SINOMED
Kinhely Bio-Tech
Shandong Huaan Biotechnology
Blue Sail Medical
Shanghai Bio-heart Biological Technology
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Rapamycin Coated Stent product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Rapamycin Coated Stent, with price, sales quantity, revenue, and global market share of Rapamycin Coated Stent from 2020 to 2025.
Chapter 3, the Rapamycin Coated Stent competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Rapamycin Coated Stent breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Rapamycin Coated Stent market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Rapamycin Coated Stent.
Chapter 14 and 15, to describe Rapamycin Coated Stent sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Rapamycin Coated Stent Consumption Value by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Cobalt Chromium Alloy Material
    • 1.3.3 Stainless Steel Material
    • 1.3.4 Others
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Rapamycin Coated Stent Consumption Value by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Hospital
    • 1.4.3 Clinic
    • 1.4.4 Others
  • 1.5 Global Rapamycin Coated Stent Market Size & Forecast
    • 1.5.1 Global Rapamycin Coated Stent Consumption Value (2020 & 2024 & 2031)
    • 1.5.2 Global Rapamycin Coated Stent Sales Quantity (2020-2031)
    • 1.5.3 Global Rapamycin Coated Stent Average Price (2020-2031)

2 Manufacturers Profiles

  • 2.1 QualiMe
    • 2.1.1 QualiMe Details
    • 2.1.2 QualiMe Major Business
    • 2.1.3 QualiMe Rapamycin Coated Stent Product and Services
    • 2.1.4 QualiMe Rapamycin Coated Stent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 QualiMe Recent Developments/Updates
  • 2.2 Cardionovum
    • 2.2.1 Cardionovum Details
    • 2.2.2 Cardionovum Major Business
    • 2.2.3 Cardionovum Rapamycin Coated Stent Product and Services
    • 2.2.4 Cardionovum Rapamycin Coated Stent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Cardionovum Recent Developments/Updates
  • 2.3 MicroPort
    • 2.3.1 MicroPort Details
    • 2.3.2 MicroPort Major Business
    • 2.3.3 MicroPort Rapamycin Coated Stent Product and Services
    • 2.3.4 MicroPort Rapamycin Coated Stent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 MicroPort Recent Developments/Updates
  • 2.4 B. Braun
    • 2.4.1 B. Braun Details
    • 2.4.2 B. Braun Major Business
    • 2.4.3 B. Braun Rapamycin Coated Stent Product and Services
    • 2.4.4 B. Braun Rapamycin Coated Stent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 B. Braun Recent Developments/Updates
  • 2.5 P+F Products + Features GmbH
    • 2.5.1 P+F Products + Features GmbH Details
    • 2.5.2 P+F Products + Features GmbH Major Business
    • 2.5.3 P+F Products + Features GmbH Rapamycin Coated Stent Product and Services
    • 2.5.4 P+F Products + Features GmbH Rapamycin Coated Stent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 P+F Products + Features GmbH Recent Developments/Updates
  • 2.6 Terumo
    • 2.6.1 Terumo Details
    • 2.6.2 Terumo Major Business
    • 2.6.3 Terumo Rapamycin Coated Stent Product and Services
    • 2.6.4 Terumo Rapamycin Coated Stent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Terumo Recent Developments/Updates
  • 2.7 Biotronik
    • 2.7.1 Biotronik Details
    • 2.7.2 Biotronik Major Business
    • 2.7.3 Biotronik Rapamycin Coated Stent Product and Services
    • 2.7.4 Biotronik Rapamycin Coated Stent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 Biotronik Recent Developments/Updates
  • 2.8 USM Healthcare
    • 2.8.1 USM Healthcare Details
    • 2.8.2 USM Healthcare Major Business
    • 2.8.3 USM Healthcare Rapamycin Coated Stent Product and Services
    • 2.8.4 USM Healthcare Rapamycin Coated Stent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 USM Healthcare Recent Developments/Updates
  • 2.9 Concept Medical Inc
    • 2.9.1 Concept Medical Inc Details
    • 2.9.2 Concept Medical Inc Major Business
    • 2.9.3 Concept Medical Inc Rapamycin Coated Stent Product and Services
    • 2.9.4 Concept Medical Inc Rapamycin Coated Stent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 Concept Medical Inc Recent Developments/Updates
  • 2.10 MicroPort Scientific Corporation
    • 2.10.1 MicroPort Scientific Corporation Details
    • 2.10.2 MicroPort Scientific Corporation Major Business
    • 2.10.3 MicroPort Scientific Corporation Rapamycin Coated Stent Product and Services
    • 2.10.4 MicroPort Scientific Corporation Rapamycin Coated Stent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.10.5 MicroPort Scientific Corporation Recent Developments/Updates
  • 2.11 Lepu Medical Technology
    • 2.11.1 Lepu Medical Technology Details
    • 2.11.2 Lepu Medical Technology Major Business
    • 2.11.3 Lepu Medical Technology Rapamycin Coated Stent Product and Services
    • 2.11.4 Lepu Medical Technology Rapamycin Coated Stent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.11.5 Lepu Medical Technology Recent Developments/Updates
  • 2.12 JW Medical Systems
    • 2.12.1 JW Medical Systems Details
    • 2.12.2 JW Medical Systems Major Business
    • 2.12.3 JW Medical Systems Rapamycin Coated Stent Product and Services
    • 2.12.4 JW Medical Systems Rapamycin Coated Stent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.12.5 JW Medical Systems Recent Developments/Updates
  • 2.13 SINOMED
    • 2.13.1 SINOMED Details
    • 2.13.2 SINOMED Major Business
    • 2.13.3 SINOMED Rapamycin Coated Stent Product and Services
    • 2.13.4 SINOMED Rapamycin Coated Stent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.13.5 SINOMED Recent Developments/Updates
  • 2.14 Kinhely Bio-Tech
    • 2.14.1 Kinhely Bio-Tech Details
    • 2.14.2 Kinhely Bio-Tech Major Business
    • 2.14.3 Kinhely Bio-Tech Rapamycin Coated Stent Product and Services
    • 2.14.4 Kinhely Bio-Tech Rapamycin Coated Stent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.14.5 Kinhely Bio-Tech Recent Developments/Updates
  • 2.15 Shandong Huaan Biotechnology
    • 2.15.1 Shandong Huaan Biotechnology Details
    • 2.15.2 Shandong Huaan Biotechnology Major Business
    • 2.15.3 Shandong Huaan Biotechnology Rapamycin Coated Stent Product and Services
    • 2.15.4 Shandong Huaan Biotechnology Rapamycin Coated Stent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.15.5 Shandong Huaan Biotechnology Recent Developments/Updates
  • 2.16 Blue Sail Medical
    • 2.16.1 Blue Sail Medical Details
    • 2.16.2 Blue Sail Medical Major Business
    • 2.16.3 Blue Sail Medical Rapamycin Coated Stent Product and Services
    • 2.16.4 Blue Sail Medical Rapamycin Coated Stent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.16.5 Blue Sail Medical Recent Developments/Updates
  • 2.17 Shanghai Bio-heart Biological Technology
    • 2.17.1 Shanghai Bio-heart Biological Technology Details
    • 2.17.2 Shanghai Bio-heart Biological Technology Major Business
    • 2.17.3 Shanghai Bio-heart Biological Technology Rapamycin Coated Stent Product and Services
    • 2.17.4 Shanghai Bio-heart Biological Technology Rapamycin Coated Stent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.17.5 Shanghai Bio-heart Biological Technology Recent Developments/Updates

3 Competitive Environment: Rapamycin Coated Stent by Manufacturer

  • 3.1 Global Rapamycin Coated Stent Sales Quantity by Manufacturer (2020-2025)
  • 3.2 Global Rapamycin Coated Stent Revenue by Manufacturer (2020-2025)
  • 3.3 Global Rapamycin Coated Stent Average Price by Manufacturer (2020-2025)
  • 3.4 Market Share Analysis (2024)
    • 3.4.1 Producer Shipments of Rapamycin Coated Stent by Manufacturer Revenue ($MM) and Market Share (%): 2024
    • 3.4.2 Top 3 Rapamycin Coated Stent Manufacturer Market Share in 2024
    • 3.4.3 Top 6 Rapamycin Coated Stent Manufacturer Market Share in 2024
  • 3.5 Rapamycin Coated Stent Market: Overall Company Footprint Analysis
    • 3.5.1 Rapamycin Coated Stent Market: Region Footprint
    • 3.5.2 Rapamycin Coated Stent Market: Company Product Type Footprint
    • 3.5.3 Rapamycin Coated Stent Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Rapamycin Coated Stent Market Size by Region
    • 4.1.1 Global Rapamycin Coated Stent Sales Quantity by Region (2020-2031)
    • 4.1.2 Global Rapamycin Coated Stent Consumption Value by Region (2020-2031)
    • 4.1.3 Global Rapamycin Coated Stent Average Price by Region (2020-2031)
  • 4.2 North America Rapamycin Coated Stent Consumption Value (2020-2031)
  • 4.3 Europe Rapamycin Coated Stent Consumption Value (2020-2031)
  • 4.4 Asia-Pacific Rapamycin Coated Stent Consumption Value (2020-2031)
  • 4.5 South America Rapamycin Coated Stent Consumption Value (2020-2031)
  • 4.6 Middle East & Africa Rapamycin Coated Stent Consumption Value (2020-2031)

5 Market Segment by Type

  • 5.1 Global Rapamycin Coated Stent Sales Quantity by Type (2020-2031)
  • 5.2 Global Rapamycin Coated Stent Consumption Value by Type (2020-2031)
  • 5.3 Global Rapamycin Coated Stent Average Price by Type (2020-2031)

6 Market Segment by Application

  • 6.1 Global Rapamycin Coated Stent Sales Quantity by Application (2020-2031)
  • 6.2 Global Rapamycin Coated Stent Consumption Value by Application (2020-2031)
  • 6.3 Global Rapamycin Coated Stent Average Price by Application (2020-2031)

7 North America

  • 7.1 North America Rapamycin Coated Stent Sales Quantity by Type (2020-2031)
  • 7.2 North America Rapamycin Coated Stent Sales Quantity by Application (2020-2031)
  • 7.3 North America Rapamycin Coated Stent Market Size by Country
    • 7.3.1 North America Rapamycin Coated Stent Sales Quantity by Country (2020-2031)
    • 7.3.2 North America Rapamycin Coated Stent Consumption Value by Country (2020-2031)
    • 7.3.3 United States Market Size and Forecast (2020-2031)
    • 7.3.4 Canada Market Size and Forecast (2020-2031)
    • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

  • 8.1 Europe Rapamycin Coated Stent Sales Quantity by Type (2020-2031)
  • 8.2 Europe Rapamycin Coated Stent Sales Quantity by Application (2020-2031)
  • 8.3 Europe Rapamycin Coated Stent Market Size by Country
    • 8.3.1 Europe Rapamycin Coated Stent Sales Quantity by Country (2020-2031)
    • 8.3.2 Europe Rapamycin Coated Stent Consumption Value by Country (2020-2031)
    • 8.3.3 Germany Market Size and Forecast (2020-2031)
    • 8.3.4 France Market Size and Forecast (2020-2031)
    • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
    • 8.3.6 Russia Market Size and Forecast (2020-2031)
    • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

  • 9.1 Asia-Pacific Rapamycin Coated Stent Sales Quantity by Type (2020-2031)
  • 9.2 Asia-Pacific Rapamycin Coated Stent Sales Quantity by Application (2020-2031)
  • 9.3 Asia-Pacific Rapamycin Coated Stent Market Size by Region
    • 9.3.1 Asia-Pacific Rapamycin Coated Stent Sales Quantity by Region (2020-2031)
    • 9.3.2 Asia-Pacific Rapamycin Coated Stent Consumption Value by Region (2020-2031)
    • 9.3.3 China Market Size and Forecast (2020-2031)
    • 9.3.4 Japan Market Size and Forecast (2020-2031)
    • 9.3.5 South Korea Market Size and Forecast (2020-2031)
    • 9.3.6 India Market Size and Forecast (2020-2031)
    • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
    • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

  • 10.1 South America Rapamycin Coated Stent Sales Quantity by Type (2020-2031)
  • 10.2 South America Rapamycin Coated Stent Sales Quantity by Application (2020-2031)
  • 10.3 South America Rapamycin Coated Stent Market Size by Country
    • 10.3.1 South America Rapamycin Coated Stent Sales Quantity by Country (2020-2031)
    • 10.3.2 South America Rapamycin Coated Stent Consumption Value by Country (2020-2031)
    • 10.3.3 Brazil Market Size and Forecast (2020-2031)
    • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

  • 11.1 Middle East & Africa Rapamycin Coated Stent Sales Quantity by Type (2020-2031)
  • 11.2 Middle East & Africa Rapamycin Coated Stent Sales Quantity by Application (2020-2031)
  • 11.3 Middle East & Africa Rapamycin Coated Stent Market Size by Country
    • 11.3.1 Middle East & Africa Rapamycin Coated Stent Sales Quantity by Country (2020-2031)
    • 11.3.2 Middle East & Africa Rapamycin Coated Stent Consumption Value by Country (2020-2031)
    • 11.3.3 Turkey Market Size and Forecast (2020-2031)
    • 11.3.4 Egypt Market Size and Forecast (2020-2031)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
    • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

  • 12.1 Rapamycin Coated Stent Market Drivers
  • 12.2 Rapamycin Coated Stent Market Restraints
  • 12.3 Rapamycin Coated Stent Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Rapamycin Coated Stent and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Rapamycin Coated Stent
  • 13.3 Rapamycin Coated Stent Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Rapamycin Coated Stent Typical Distributors
  • 14.3 Rapamycin Coated Stent Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Rapamycin Coated Stent. Industry analysis & Market Report on Rapamycin Coated Stent is a syndicated market report, published as Global Rapamycin Coated Stent Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031. It is complete Research Study and Industry Analysis of Rapamycin Coated Stent market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo